Frazier Life Sciences Management as of Sept. 30, 2025
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 47 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | 14.9 | $498M | 6.8M | 73.31 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 14.2 | $475M | 17M | 28.44 | |
| Verona Pharma Sponsored Ads (VRNA) | 10.8 | $361M | 3.4M | 106.71 | |
| Bridgebio Pharma (BBIO) | 6.0 | $200M | 3.8M | 51.94 | |
| Arcutis Biotherapeutics (ARQT) | 5.6 | $186M | 9.9M | 18.85 | |
| Phathom Pharmaceuticals (PHAT) | 4.4 | $147M | 13M | 11.77 | |
| Krystal Biotech (KRYS) | 3.6 | $122M | 689k | 176.53 | |
| Maze Therapeatics (MAZE) | 3.5 | $118M | 4.6M | 25.93 | |
| Mbx Biosciences (MBX) | 3.5 | $116M | 6.7M | 17.50 | |
| Disc Medicine (IRON) | 2.8 | $95M | 1.4M | 66.08 | |
| Trevi Therapeutics (TRVI) | 2.8 | $94M | 10M | 9.15 | |
| Tarsus Pharmaceuticals (TARS) | 2.1 | $69M | 1.2M | 59.43 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $61M | 5.0M | 12.18 | |
| Zai Lab Adr (ZLAB) | 1.7 | $55M | 1.6M | 33.89 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $51M | 1.3M | 40.14 | |
| Erasca (ERAS) | 1.5 | $50M | 23M | 2.18 | |
| Cytokinetics Com New (CYTK) | 1.5 | $49M | 890k | 54.96 | |
| Revolution Medicines (RVMD) | 1.4 | $47M | 998k | 46.70 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.4 | $45M | 722k | 62.69 | |
| Savara (SVRA) | 1.2 | $41M | 12M | 3.57 | |
| Dyne Therapeutics (DYN) | 1.0 | $34M | 2.7M | 12.65 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.0 | $32M | 378k | 84.90 | |
| Aura Biosciences (AURA) | 0.9 | $32M | 5.1M | 6.18 | |
| Ultragenyx Pharmaceutical (RARE) | 0.9 | $30M | 984k | 30.08 | |
| Lexeo Therapeutics (LXEO) | 0.9 | $29M | 4.4M | 6.64 | |
| Valneva Se Sponsored Ads (VALN) | 0.8 | $28M | 2.3M | 12.20 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $27M | 625k | 43.57 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $27M | 133k | 198.81 | |
| Alkermes SHS (ALKS) | 0.6 | $21M | 701k | 30.00 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $19M | 9.4M | 2.06 | |
| Akero Therapeutics (AKRO) | 0.5 | $17M | 367k | 47.48 | |
| Vaxcyte (PCVX) | 0.5 | $17M | 474k | 36.02 | |
| Evolus (EOLS) | 0.5 | $16M | 2.6M | 6.14 | |
| Design Therapeutics (DSGN) | 0.4 | $15M | 2.0M | 7.53 | |
| Immunocore Hldgs Ads (IMCR) | 0.4 | $14M | 385k | 36.33 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $13M | 614k | 21.34 | |
| Jade Biosciences Com New (JBIO) | 0.4 | $12M | 1.4M | 8.63 | |
| Assembly Biosciences Com New (ASMB) | 0.3 | $12M | 456k | 25.60 | |
| Adverum Biotechnologies Com New (ADVM) | 0.3 | $9.4M | 2.1M | 4.53 | |
| Travere Therapeutics (TVTX) | 0.3 | $9.4M | 392k | 23.90 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.3 | $8.6M | 500k | 17.11 | |
| Engene Holdings (ENGN) | 0.2 | $7.9M | 1.2M | 6.83 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $7.5M | 4.6M | 1.63 | |
| Macrogenics (MGNX) | 0.2 | $5.3M | 3.2M | 1.68 | |
| Silence Therapeutics Ads (SLN) | 0.2 | $5.0M | 970k | 5.19 | |
| Allogene Therapeutics (ALLO) | 0.1 | $4.8M | 3.9M | 1.24 | |
| Crescent Biopharma (CBIO) | 0.1 | $3.2M | 273k | 11.89 |
